{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T22:06:03Z","timestamp":1785189963705,"version":"3.55.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.vaccine.2017.10.105","type":"journal-article","created":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T17:01:17Z","timestamp":1510333277000},"page":"7302-7308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Beneficiary characteristics and vaccinations in the end-stage renal disease Medicare beneficiary population, an analysis of claims data 2006\u20132015"],"prefix":"10.1016","volume":"35","author":[{"given":"Angela K.","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Kelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Warnock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephaeno","family":"Brereton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"McKean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wernecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce G.","family":"Gellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.10.105_b0005","unstructured":"Chi C, Patel P, Pilishvili T, Moore M, Murphy T, Strikas S. Guidelines for vaccinating kidney dialysis patients and patients with chronic kidney disease summarized from recommendations of the Advisory Committee on Immunization Practice (ACIP); 2012. <http:\/\/www.cdc.gov\/dialysis\/PDFs\/Vaccinating_Dialysis_Patients_and_Patients_dec2012.pdf> [accessed 24 October 2016]."},{"key":"10.1016\/j.vaccine.2017.10.105_b0010","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.510290132","article-title":"Preventing hepatitis B and hepatitis C virus infectious in end-stage renal disease patients: back to basics","volume":"29","author":"Kellerman","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.vaccine.2017.10.105_b0015","unstructured":"U.S. Department of Health and Human Services, U.S. Department of Defense, U.S. Department of Veterans Affairs. National action plan to prevent health care-associated infections: Road map to elimination. Office of Disease Prevention and Health Promotion; 2013 [accessed 24 October 2016]."},{"key":"10.1016\/j.vaccine.2017.10.105_b0020","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1681\/ASN.2008090954","article-title":"Association of preventive health care with atherosclerotic heart disease and mortality in CKD","volume":"20","author":"Snyder","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.vaccine.2017.10.105_b0025","unstructured":"United States renal data system annual data report 2015: epidemiology of kidney disease in the United States. United States Renal Data System. <https:\/\/www.usrds.org\/adr.aspx> [accessed 24 October 2016]."},{"issue":"3","key":"10.1016\/j.vaccine.2017.10.105_b0030","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/ndt\/gfm851","article-title":"Vaccination and chronic kidney disease","volume":"23","author":"Janus","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.vaccine.2017.10.105_b0035","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1046\/j.1523-1755.2003.00787.x","article-title":"Influenza vaccine delivery and effectiveness in end-stage renal disease","volume":"63","author":"Gilbertson","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.vaccine.2017.10.105_b0040","unstructured":"Centers for Disease Control and Prevention. Healthcare-associated hepatitis B and C outbreaks reported to the centers for disease control and prevention (CDC) 2008\u20132015. Centers for Disease Control and Prevention; 2016. <http:\/\/www.cdc.gov\/hepatitis\/outbreaks\/healthcarehepoutbreaktable.htm> [accessed 24 October 2016]."},{"key":"10.1016\/j.vaccine.2017.10.105_b0045","unstructured":"End-Stage Renal Disease Network Program. Facilities involved in vaccinations QIA. Vaccination QIA. <http:\/\/esrd.ipro.org\/vaccination-qia\/> [accessed 25 October 2016]."},{"key":"10.1016\/j.vaccine.2017.10.105_b0050","unstructured":"Healthy People 2020; 2017 . <https:\/\/www.healthypeople.gov> [accessed 6 September 2017]."},{"key":"10.1016\/j.vaccine.2017.10.105_b0055","doi-asserted-by":"crossref","unstructured":"Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP); 2012. <https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm6140a4.htm> 2012 [accessed 5 December 2016].","DOI":"10.1111\/ajt.12073"},{"issue":"34","key":"10.1016\/j.vaccine.2017.10.105_b0060","doi-asserted-by":"crossref","first-page":"944","DOI":"10.15585\/mmwr.mm6434a4","article-title":"Intervals between PCV13 and PPSV23 vaccines: recommendations of the advisory committee on immunization practices (ACIP)","volume":"64","author":"Kobayashi","year":"2016","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2017.10.105_b0065","unstructured":"Centers for Medicare & Medicaid Services. ESRD \u2013 general information. centers for medicare & medicaid services; 2016. <https:\/\/www.cms.gov\/Medicare\/End-Stage-Renal-Disease\/ESRDGeneralInformation\/index.html> [accessed 24 October 2016]."},{"key":"10.1016\/j.vaccine.2017.10.105_b0070","unstructured":"Geographic terms and concepts \u2013 core based statistical areas and related statistical areas; 2012. <https:\/\/www.census.gov\/geo\/reference\/gtc\/gtc_cbsa.html> [accessed 7 September 2017]."},{"key":"10.1016\/j.vaccine.2017.10.105_b0075","unstructured":"Office of Disease Prevention and Health Promotion. Health people 2020: immunization and infectious diseases. Office of Disease Prevention and Health Promotion; 2016. <https:\/\/www.healthypeople.gov\/2020\/topics-objectives\/topic\/immunization-and-infectious-diseases\/objectives> [accessed 24 October 2016]."},{"key":"10.1016\/j.vaccine.2017.10.105_b0080","unstructured":"United States Renal Data System. Chapter 6: mortality; 2017. <https:\/\/www.usrds.org\/2016\/view\/v2_06.aspx> [accessed 24 October 2016]."},{"key":"10.1016\/j.vaccine.2017.10.105_b0085","first-page":"109","article-title":"Hemodialysis and hepatitis B vaccination: a challenge to physicians","volume":"7","author":"Ayub","year":"2014","journal-title":"Int J Gen Med"},{"issue":"4 Suppl 1","key":"10.1016\/j.vaccine.2017.10.105_b0090","first-page":"S71","article-title":"Network 12 hepatitis B vaccination quality improvement program: an educational program directed at physicians, staff, and patients","volume":"7","author":"Coyne","year":"2000","journal-title":"Adv Ren Replace Ther"},{"key":"10.1016\/j.vaccine.2017.10.105_b0095","unstructured":"The Renal Network: ESRD Network 10. Quality improvement. The renal network ESRD network 10. <http:\/\/www.therenalnetwork.org\/qi\/quality_improvement.html> [accessed 25 October 2016]."},{"issue":"4 Suppl 1","key":"10.1016\/j.vaccine.2017.10.105_b0100","first-page":"S95","article-title":"Improved hepatitis B vaccination rates in ESRD patients in California","volume":"7","author":"Brown","year":"2000","journal-title":"Adv Ren Replace Ther"},{"issue":"4 Suppl 1","key":"10.1016\/j.vaccine.2017.10.105_b0105","first-page":"S81","article-title":"Influenza immunization rates in the intermoutain end-stage renal disease network (network 15)","volume":"7","author":"Rodgers","year":"2000","journal-title":"Adv Ren Replace Ther"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17315372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17315372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T00:41:43Z","timestamp":1570322503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17315372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":21,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0264410X17315372"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.105","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beneficiary characteristics and vaccinations in the end-stage renal disease Medicare beneficiary population, an analysis of claims data 2006\u20132015","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}